British Journal of Cancer ~ Volume 100, Issue 10, 12 May 2009 pp1517-1696 Journal, Issue, Cancer, Volume, British

药学论坛

British Journal of Cancer " Volume 100, Issue 10, 12 May 2009 pp1517-1696

by:?NPG   


  
Table of contentsVolume 100, Issue 10
12 May 2009 (1517-1696)
Minireviews |
Clinical Studies |
Translational Therapeutics |
Molecular Diagnostics |
Genetics and Genomics
Top of page Minireviews
Molecular classification of solid tumours: towards pathway-driven therapeutics
C Swanton and C Caldas  
Br J Cancer 100: 1517-1522; advance online publication, April 14, 2009; doi:10.1038/sj.bjc.6605031  
?  
Targeting HSP90 for cancer therapy
D Mahalingam, R Swords, J S Carew, S T Nawrocki, K Bhalla and F J Giles  
Br J Cancer 100: 1523-1529; advance online publication, April 28, 2009; doi:10.1038/sj.bjc.6605066  
?  
Clinical Studies
Positive lymph node retrieval ratio optimises patient staging in colorectal cancer
S J Moug, J D Saldanha, J R McGregor, M Balsitis and R H Diament  
Br J Cancer 100: 1530-1533; advance online publication, April 28, 2009; doi:10.1038/sj.bjc.6605049  
?  
Long-range epigenetic silencing at 2q14.2 affects most human colorectal cancers and may have application as a non-invasive biomarker of disease
R Mayor, L Casadomé, D Azuara, V Moreno, S J Clark, G Capellà and M A Peinado  
Br J Cancer 100: 1534-1539; advance online publication, April 21, 2009; doi:10.1038/sj.bjc.6605045  
?  
High expression of tumour-associated trypsin inhibitor correlates with liver metastasis and poor prognosis in colorectal cancer
A Gaber, M Johansson, U-H Stenman, K Hotakainen, F Pontén, B Glimelius, A Bjartell, K Jirstr?m and H Birgisson  
Br J Cancer 100: 1540-1548; advance online publication, April 21, 2009; doi:10.1038/sj.bjc.6605047  
?  
Predictors of survival and toxicity in patients on adjuvant therapy with 5-fluorouracil for colorectal cancer
M Gusella, A C Frigo, C Bolzonella, R Marinelli, C Barile, A Bononi, G Crepaldi, D Menon, L Stievano, S Toso, F Pasini, E Ferrazzi and R Padrini  
Br J Cancer 100: 1549-1557; advance online publication, April 21, 2009; doi:10.1038/sj.bjc.6605052  
?  
The impact of radiotherapy late effects on quality of life in gynaecological cancer patients
C L Barker, J A Routledge, D J J Farnell, R Swindell and S E Davidson  
Br J Cancer 100: 1558-1565; advance online publication, April 21, 2009; doi:10.1038/sj.bjc.6605050  

Pattern and quality of care of cancer pain management. Results from the Cancer Pain Outcome Research Study Group
G Apolone, O Corli, A Caraceni, E Negri, S Deandrea, M Montanari and M T Greco on behalf of the Cancer Pain Outcome Research Study Group (CPOR SG) Investigators  
Br J Cancer 100: 1566-1574; advance online publication, April 28, 2009; doi:10.1038/sj.bjc.6605053  

Translational Therapeutics
Inhibition of tyrosine kinase receptors by SU6668 promotes abnormal stromal development at the periphery of carcinomas
P Farace, M Galiè, F Merigo, A Daducci, L Calderan, E Nicolato, A Degrassi, E Pesenti, A Sbarbati and P Marzola  
Br J Cancer 100: 1575-1580; advance online publication, April 21, 2009; doi:10.1038/sj.bjc.6605041  

Prophylactic ciprofloxacin treatment prevented high mortality, and modified systemic and intestinal immune function in tumour-bearing rats receiving dose-intensive CPT-11 chemotherapy
H Xue, C J Field, M B Sawyer, L A Dieleman and V E Baracos  
Br J Cancer 100: 1581-1588; advance online publication, April 28, 2009; doi:10.1038/sj.bjc.6605051  
?  
Bacterial endotoxin enhances colorectal cancer cell adhesion and invasion through TLR-4 and NF-B-dependent activation of the urokinase plasminogen activator system
S D Killeen, J H Wang, E J Andrews and H P Redmond  
Br J Cancer 100: 1589-1602; doi:10.1038/sj.bjc.6604942  
?  

Molecular Diagnostics
Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer
J Nilsson, J Skog, A Nordstrand, V Baranov, L Mincheva-Nilsson, X O Breakefield and A Widmark  
Br J Cancer 100: 1603-1607; advance online publication, April 28, 2009; doi:10.1038/sj.bjc.6605058  

Heterogeneous nuclear ribonucleoprotein K: altered pattern of expression associated with diagnosis and prognosis of prostate cancer
P Barboro, E Repaci, A Rubagotti, S Salvi, S Boccardo, B Spina, M Truini, C Introini, P Puppo, N Ferrari, G Carmignani, F Boccardo and C Balbi  
Br J Cancer 100: 1608-1616; advance online publication, April 28, 2009; doi:10.1038/sj.bjc.6605057  

Expression of endoglin (CD105) in cervical cancer
H J Zijlmans, G J Fleuren, S Hazelbag, C F Sier, E J Dreef, G G Kenter and A Gorter  
Br J Cancer 100: 1617-1626; advance online publication, April 7, 2009; doi:10.1038/sj.bjc.6605009  

Consensus criteria for sensitive detection of minimal neuroblastoma cells in bone marrow, blood and stem cell preparations by immunocytology and QRT-PCR: recommendations by the International Neuroblastoma Risk Group Task Force
K Beiske, S A Burchill, I Y Cheung, E Hiyama, R C Seeger, S L Cohn, A D J Pearson and K K Matthay  
Br J Cancer 100: 1627-1637; advance online publication, April 28, 2009; doi:10.1038/sj.bjc.6605029  
?  
CXCR1 and CXCR2 enhances human melanoma tumourigenesis, growth and invasion
S Singh, K C Nannuru, A Sadanandam, M L Varney and R K Singh  
Br J Cancer 100: 1638-1646; advance online publication, April 28, 2009; doi:10.1038/sj.bjc.6605055  
?  
Activation of Wnt/-catenin signalling pathway induces chemoresistance to interferon-/5-fluorouracil combination therapy for hepatocellular carcinoma
T Noda, H Nagano, I Takemasa, S Yoshioka, M Murakami, H Wada, S Kobayashi, S Marubashi, Y Takeda, K Dono, K Umeshita, N Matsuura, K Matsubara, Y Doki, M Mori and M Monden  
Br J Cancer 100: 1647-1658; advance online publication, April 28, 2009; doi:10.1038/sj.bjc.6605064  
?  
The use of kallikrein-related peptidases as adjuvant prognostic markers in colorectal cancer
M Talieri, L Li, Y Zheng, D K Alexopoulou, A Soosaipillai, A Scorilas, D Xynopoulos and E P Diamandis  
Br J Cancer 100: 1659-1665; advance online publication, April 14, 2009; doi:10.1038/sj.bjc.6605033  
?  
Hypoxia-inducible factor-1 and -2 are expressed in most rectal cancers but only hypoxia-inducible factor-1 is associated with prognosis
S Rasheed, A L Harris, P P Tekkis, H Turley, A Silver, P J McDonald, I C Talbot, R Glynne-Jones, J M A Northover and T Guenther  
Br J Cancer 100: 1666-1673; doi:10.1038/sj.bjc.6605026  
?  

Genetics and Genomics
TGFBR1 variants TGFBR1 *6A and Int7G24A are not associated with an increased familial colorectal cancer risk
J Skoglund Lundin, J Vandrovcova, B Song, X Zhou, M Zelada-Hedman, B Werelius, R S Houlston and A Lindblom  
Br J Cancer 100: 1674-1679; advance online publication, April 28, 2009; doi:10.1038/sj.bjc.6605054  

Genetic polymorphisms in DNA repair and damage response genes and late normal tissue complications of radiotherapy for breast cancer
J Chang-Claude, C B Ambrosone, C Lilla, S Kropp, I Helmbold, D von Fournier, W Haase, M-L Sautter-Bihl, F Wenz, P Schmezer and O Popanda  
Br J Cancer 100: 1680-1686; advance online publication, April 14, 2009; doi:10.1038/sj.bjc.6605036  
?  
The prolyl 3-hydroxylases P3H2 and P3H3 are novel targets for epigenetic silencing in breast cancer
R Shah, P Smith, C Purdie, P Quinlan, L Baker, P Aman, A M Thompson and T Crook  
Br J Cancer 100: 1687-1696; doi:10.1038/sj.bjc.6605042                   http://rapidshare.com/files/234252247/Volume_100__Issue_10.rar